Nils-Erik Stjernstrom

Title: Nils-Erik Stjernstrom: Innovator in Pharmaceutical Chemistry

Introduction

Nils-Erik Stjernstrom is a notable inventor based in Sodertalje, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating depressive states.

Latest Patents

Stjernstrom holds a patent for "Compounds of diphenylcyclopentylamine type and methods for their preparation." This patent includes compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof. The compounds feature variations where X and Y can represent a hydrogen atom, a chloro, or a methoxy group. The integer n can be either 0 or 1, while R¹ and R² can be hydrogen atoms or methyl groups. The patent outlines processes for preparing these compounds, pharmaceutical preparations containing them, and their use in treating depressive states. He has 1 patent to his name.

Career Highlights

Stjernstrom is associated with Astra Lakemedel Aktiebolaget, a company known for its focus on pharmaceutical innovations. His work has contributed to advancements in mental health treatments, showcasing his commitment to improving patient outcomes.

Collaborations

Throughout his career, Stjernstrom has collaborated with esteemed colleagues, including Bernt Sigfrid Carnmalm and Ulf H Lindberg. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Nils-Erik Stjernstrom's contributions to pharmaceutical chemistry, particularly in the area of compounds for treating depressive states, highlight his innovative spirit and dedication to improving mental health treatments. His work continues to influence the field and offers hope for better therapeutic options.